Cargando…

Fluoroquinolones Protective against Cephalosporin Resistance in Gram-negative Nosocomial Pathogens

In a matched case-control study, we studied the effect of prior receipt of fluoroquinolones on isolation of three third-generation cephalosporin-resistant gram-negative nosocomial pathogens. Two hundred eighty-two cases with a third-generation cephalosporin-resistant pathogen (203 with Enterobacter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwaber, Mitchell J., Cosgrove, Sara E., Gold, Howard S., Kaye, Keith S., Carmeli, Yehuda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2004
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322754/ https://www.ncbi.nlm.nih.gov/pubmed/15078603 http://dx.doi.org/10.3201/eid1001.020663

Ejemplares similares

Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients
por: Weber, Stephen G., et al.
Publicado: (2003)

Antimicrobial resistance and patient outcomes: the hazards of adjustment
por: Schwaber, Mitchell J, et al.
Publicado: (2006)

The effect of antimicrobial resistance on patient outcomes: importance of proper evaluation of appropriate therapy
por: Schwaber, Mitchell J, et al.
Publicado: (2009)

Emergence of integron borne PER-1 mediated extended spectrum cephalosporin resistance among nosocomial isolates of Gram-negative bacilli
por: Maurya, Anand Prakash, et al.
Publicado: (2015)

Risk for primary cephalosporin resistance in Gram-negative bacteremia
por: John, Princy, et al.
Publicado: (2023)

Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone.
por: Lee, K., et al.
Publicado: (2001)

Novel Fluoroquinolones with Possible Antibacterial Activity in Gram-Negative Resistant Pathogens: In Silico Drug Discovery
por: Coba-Males, Manuel Alejandro, et al.
Publicado: (2023)

258. A Comparison of Cefprozil and Fluoroquinolones for Gram-Negative Bacteremia
por: Nolen, Rebecca C, et al.
Publicado: (2020)

Emergence of Resistance to Fluoroquinolones and Third-Generation Cephalosporins in Salmonella Typhi in Lahore, Pakistan
por: Rasheed, Farhan, et al.
Publicado: (2020)

A retrospective review of oral cephalosporins versus fluoroquinolones for the treatment of pyelonephritis
por: Lin, Kevin, et al.
Publicado: (2022)

1787. County Level Association Between the Rate of Fluoroquinolone-Resistance Gram Negative Bacteria and Fluoroquinolone Utilization in Kansas
por: Fulmer, Robert D, et al.
Publicado: (2022)

Fluoroquinolone Resistance Among Gram-Negative Urinary Tract Pathogens: Global Smart Program Results, 2009-2010
por: Bouchillon, Sam, et al.
Publicado: (2012)

Effective Antimicrobial Solutions for Eradicating Multi-Resistant and β-Lactamase-Producing Nosocomial Gram-Negative Pathogens
por: Meade, Elaine, et al.
Publicado: (2021)

1044. Aztreonam (AZT) vs. Cephalosporin (CEP) Therapy for the Treatment of Gram-Negative Bacteremia
por: Shah, Sunish, et al.
Publicado: (2018)

Hot-spot consensus of fluoroquinolone-mediated DNA cleavage by Gram-negative and Gram-positive type II DNA topoisomerases
por: Richter, Sara N., et al.
Publicado: (2007)

Antimicrobial use trends, Israel, 2012 to 2017
por: Dickstein, Yaakov, et al.
Publicado: (2019)

715 Impact of Fluoroquinolone Resistance on Community-Onset Gram-Negative Bloodstream Infections
por: Brigmon, Matthew, et al.
Publicado: (2014)

Molecular characterization of fluoroquinolone and/or cephalosporin resistance in Shigella sonnei isolates from yaks
por: Zhu, Zhen, et al.
Publicado: (2018)

1459. Oral Cephalosporins vs. Fluoroquinolones for the Empiric Treatment of Acute Uncomplicated Pyelonephritis
por: Lin, Kevin, et al.
Publicado: (2019)

Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and Clostridioides difficile Infections
por: Wren, Callyn Mariah, et al.
Publicado: (2022)

Clinical Significance of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Schwaber, Mitchell J., et al.
Publicado: (2003)

Antimicrobial resistance pattern of gram negative bacteria to 3rd and 4th generation cephalosporins
por: Revathi, P, et al.
Publicado: (2011)

In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria
por: Ito, Akinobu, et al.
Publicado: (2017)

252 S-649266, a Novel Siderophore Cephalosporin: In vitro activity against Gram-negative bacteria
por: Tsuji, Masakatsu, et al.
Publicado: (2014)

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria
por: Mushtaq, Shazad, et al.
Publicado: (2020)

Acinetobacter baumannii Bloodstream Infections: A Nationwide Study in Israel
por: Nutman, Amir, et al.
Publicado: (2023)

Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review
por: Soriano, Alex, et al.
Publicado: (2021)

N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria
por: Laws, Mark, et al.
Publicado: (2020)

647. Adoption of the updated fluoroquinolones breakpoints for Gram negative bacteria in clinical microbiology laboratories
por: Sfeir, Maroun M
Publicado: (2020)

Improvement of Gram-negative Susceptibility to Fluoroquinolones After Implementation of a Pre-Authorization Policy for Fluoroquinolone Use: A Decade-Long Experience
por: Lee, Rachael A, et al.
Publicado: (2017)

Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern
por: Park, Sun Hee
Publicado: (2014)

Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects
por: Saisho, Yutaka, et al.
Publicado: (2018)

Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment
por: Katsube, Takayuki, et al.
Publicado: (2016)

Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial Origin
por: Tsering, Dechen C, et al.
Publicado: (2009)

Gram-Negative Rods on Inanimate Surfaces of Selected Hospital Facilities and Their Nosocomial Significance
por: Zahornacký, Ondrej, et al.
Publicado: (2022)

363 Persistence of the Klebsiella pneumoniae Sequence Type 258 as the Predominant Clone of Carbapenemase-Producing Enterobacteriaceae in Post-Acute Care Facilities in Israel, 2008-2013
por: Adler, Amos, et al.
Publicado: (2014)

2088. Association Between Implementation of Prevention Practices and CLABSI Incidence: A National Survey
por: David, Debby Ben, et al.
Publicado: (2018)

Trends in antimicrobial resistance in Israel, 2014–2017
por: Dickstein, Yaakov, et al.
Publicado: (2019)

Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure
por: Fisman, David, et al.
Publicado: (2014)

Bacillus subtilis TR47II as a source of bioactive lipopeptides against Gram-negative pathogens causing nosocomial infections
por: de Souza Freitas, Fernanda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_en78nf027rqss54bhflkbdikcu